CAG
IBRX icon

Crestwood Advisors Group’s ImmunityBio IBRX Stock Holding History

Crestwood Advisors Group’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$59.1K Buy
22,387
+187
+0.8% +$494 ﹤0.01% 525
2025
Q1 		$66.8K Buy
22,200
+6,000
+37% +$18.1K ﹤0.01% 490
2024
Q4 		$41.5K Buy
+16,200
New +$41.5K ﹤0.01% 454